BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

7.69

+0.06 (0.79%)

At close: Nov 6, 2026, 4:00 PM EST

7.71

+0.02 (0.26%)

After-hours: Nov 6, 2026, 7:30 PM EST

BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,979	1,642	1,558	1,227	2,140	2,492
Market Cap Growth	31.07%	5.43%	26.97%	-42.68%	-14.12%	89.45%
Enterprise Value	2,432	2,112	2,070	1,675	2,435	2,603
Last Close Price	7.69	7.80	7.52	5.99	11.48	13.85

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	6.22	-	-	-	-
Forward PE	10.93	33.02	-	-	-	-
PS Ratio	2.06	1.88	3.46	3.70	7.90	15.86
PB Ratio	-	-13.78	-3.27	-2.69	-7.26	-23.29
P/FCF Ratio	5.41	4.76	-	-	-	-
P/OCF Ratio	5.38	4.73	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.53	2.42	4.59	5.05	8.99	16.56
EV/EBITDA Ratio	5.15	6.02	1194.32	-	-	-
EV/EBIT Ratio	5.19	6.08	-	-	-	-
EV/FCF Ratio	6.65	6.13	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-2.08	-4.01	-1.77	-1.86	-2.52	-5.54
Debt / EBITDA Ratio	1.74	1.35	208.58	-	-	-
Debt / FCF Ratio	2.26	1.38	-	-	-	-
Net Debt / Equity Ratio	-1.14	-1.70	-1.09	-1.01	-1.08	-0.80
Net Debt / EBITDA Ratio	0.96	0.58	300.39	-4.79	-2.17	-0.48
Net Debt / FCF Ratio	1.24	0.59	-9.79	-4.72	-1.94	-0.59
Asset Turnover	1.85	1.74	0.90	0.62	0.48	0.34
Inventory Turnover	22.17	27.17	10.10	7.70	12.00	18.93
Quick Ratio	2.54	1.95	2.49	2.97	4.50	5.18
Current Ratio	2.71	2.06	2.63	3.31	4.89	5.46
Return on Assets (ROA)	56.48%	43.21%	-0.16%	-11.57%	-16.30%	-24.07%
Return on Invested Capital (ROIC)	125.97%	105.76%	-0.37%	-24.35%	-31.96%	-49.82%
Return on Capital Employed (ROCE)	118.60%	109.20%	-0.40%	-26.90%	-33.40%	-36.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-19.42%	16.07%	-5.71%	-18.47%	-11.55%	-7.39%
FCF Yield	18.49%	21.00%	-3.41%	-7.93%	-7.63%	-5.80%
Buyback Yield / Dilution	-15.25%	-5.75%	-7.54%	-3.38%	-3.79%	-7.08%

SEC Filings: 10-K · 10-Q